A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma
The IGRPS, based on immune- and glycolysis-related genes, effectively predicted prognosis and immunotherapy responses in HCC patients.
Authors
- Shoucai Zhang
- Yongyuan Liang
- Guixi Zheng (ORCID: https://orcid.org/0000-0003-2856-9592)
- Hongxi Zhao (ORCID: https://orcid.org/0000-0002-3468-5322)
- Pengyu Wang (ORCID: https://orcid.org/0000-0002-6336-7673)
- Zeyu Zhang (ORCID: https://orcid.org/0000-0002-8657-4915)
- Yingjie Liu (ORCID: https://orcid.org/0000-0003-1634-3115)
- Jian Ji (ORCID: https://orcid.org/0000-0001-9870-4038)
- Xueyan Geng
- Maopeng Yin
Institutions
- University of Alberta (CA)
- Shandong Lianxing Energy Group (China) (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/jhc.s510460
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56